Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT01542580

A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
255 (estimated)
Sponsor
Zimmer Biomet · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate performance of the Vanguard 360 revision knee system utilizing offset on either the tibial component, femoral component, or both in terms of the restoration of mechanical alignment, clinical outcomes and survivorship.

Detailed description

This investigation is being conducted on a new complete revision knee system, Vanguard 360, which incorporates: * Fixed Bearing Knee - Vanguard SSK360 with PS Bearing and PSC Bearing * Fixed Bearing Knee - Vanguard SSK360 TiNbN Femur with PS Bearing and PSC Bearing * Mobile Bearing Knee - Vanguard DA360 (only being collected in Europe) The purpose of this study is to evaluate performance of the Vanguard 360 revision knee system utilizing offset on either the tibial component, femoral component, or both in terms of the restoration of mechanical alignment, clinical outcomes and survivorship. The efficacy and performance of the devices will be assessed by improvement of pain, function, range of motion and patient satisfaction measured pre-operatively and post-operatively. Secondary performance and safety will be determined by radiographic investigation, incidence of complications and revision rates. Surgical techniques and patient care are to be standard for the surgeon participating in the protocol. There will be no experimental or investigational devices used. There will be no experimental or investigational surgical techniques used. The devices and products will be used in accordance with their instructions for use and/or approved labeling.

Conditions

Interventions

TypeNameDescription
DEVICEVanguard SSK 360 with PS Bearingnon-constrained tibial bearing
DEVICEVanguard SSK 360 with PSC bearingconstrained tibial bearing
DEVICEVanguard DA 360Dual-articulation device, only cleared in EU
DEVICEVanguard 360 TiNbN Femur with PS bearingnon-constrained tibial bearing, titanium niobium nitride coated Vanguard 360 femur
DEVICEVanguard 360 TiNbN Femur with PSC bearingconstrained tibial bearing, titanium niobium nitride coated Vanguard 360 femur

Timeline

Start date
2012-03-01
Primary completion
2031-12-01
Completion
2031-12-01
First posted
2012-03-02
Last updated
2025-11-25

Locations

12 sites across 8 countries: United States, Belgium, Denmark, France, Germany, Italy, Spain, United Kingdom

Source: ClinicalTrials.gov record NCT01542580. Inclusion in this directory is not an endorsement.